Ramy Farid

Insider Reports History

Location
New York, NY
Signature
/s/ Vanina de Verneuil, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ramy Farid:

Company Role Class Num Shares Value Price $ Report Date Ownership
Structure Therapeutics Inc. Director American Depositary Shares 275,000 $17,176,500 $62.46 07 Feb 2023 By Schrodinger, Inc.
Schrodinger, Inc. President & CEO, Director Common Stock 221,932 $6,214,096 $28.00 03 Mar 2025 Direct
Vir Biotechnology, Inc. Director Common Stock 24,000 $147,600 $6.15 30 May 2025 Direct
Vir Biotechnology, Inc. Director Stock Option (Right to Buy) 16,000 $24,480 $1.53 30 May 2025 Direct
Structure Therapeutics Inc. Director Ordinary Shares 3,260,495 07 Feb 2023 By Schrodinger, Inc.
Schrodinger, Inc. President & CEO, Director Stock Option (right to buy) 90,000 03 Mar 2025 Direct
Structure Therapeutics Inc. Director Series B Preferred Shares 0 07 Feb 2023 By Schrodinger, Inc.

Insider Reports Filed by Ramy Farid

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VIR Vir Biotechnology, Inc. 30 May 2025 2 $0 4 Director 02 Jun 2025, 19:19
SDGR Schrodinger, Inc. 03 Mar 2025 3 $0 4 President & CEO, Director 04 Mar 2025, 17:28
VIR Vir Biotechnology, Inc. 29 May 2024 3 $0 4 Director 31 May 2024, 14:43
VIR Vir Biotechnology, Inc. 29 May 2024 0 $0 3 Director 31 May 2024, 14:42
SDGR Schrodinger, Inc. 04 Mar 2024 2 $0 4 President & CEO, Director 05 Mar 2024, 16:49
SDGR Schrodinger, Inc. 09 Feb 2023 2 $0 4 President & CEO, Director 10 Feb 2023, 16:00
GPCR Structure Therapeutics Inc. 07 Feb 2023 3 +$4,125,000 4 Director 09 Feb 2023, 18:09
GPCR Structure Therapeutics Inc. 02 Feb 2023 0 $0 3 Director 02 Feb 2023, 17:24
SDGR Schrodinger, Inc. 04 Jan 2023 3 -$1,142,406 4 President & CEO, Director 05 Jan 2023, 15:46
SDGR Schrodinger, Inc. 09 Feb 2022 1 $0 4 President & CEO, Director 09 Feb 2022, 20:13